Relevance of Somatostatin Receptors and Other Peptide Receptors in Pathology

Endocrine Pathology

Volumn 8, Issue 1, 1997, Pages 11-20

  Reubi, Jean Claude ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Peritumoral vessels; Receptor autoradiography; Regulatory peptide receptors; Somatostatin; Tumors

Indexed keywords

EID: 0002926311     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02739703     Document Type: Review

References (29)

1. Reubi JC. Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging. J Nucl Med 36:1825-1835, 1995.
2. Lamberts SWJ, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 12:450-482, 1991.
3. Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humphrey PPA, O'Carroll A, Patel YC, Schönbrunn A, Taylor JE, Reisine T. Classification and nomenclature of somatostatin receptors. Trends in Pharmacol Sci 16:86-88, 1995.
4. Reisine T, Bell GI. Molecular biology of somatostatin receptors. Endocr Rev 16:427-442, 1995.
5. Reubi JC, Krenning E, Lamberts SWJ, Kvols L. In vitro detection of somatostatin receptors in human tumors. Metabolism 41:104-110, 1992.
6. Reubi JC, Schaer JC, Waser B, Mengod G. Expression and localization of somatostatin receptor SSTR1, SSTR2 and SSTR3 mRNAs in primary human tumors using in situ hybridization. Cancer Res 54:3455-3459, 1994.
7. Greenman Y, Melmed S. Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J Clin Endocrinol Metab 79:724-729, 1994.
8. Rauly I, Saint-Laurent N, Delesque N, Buscail L, Esteve J, Vaysse N, Susini C. Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells. J Clin Invest 97:1874-1883, 1996.
9. Reubi JC, Waser B, Schaer JC, Markwalder R. Somatostatin receptors in human prostate and prostate cancer. J Clin Endocrinol Metab 80:2806-2814, 1995.
10. Buscail L, Saint-Laurent N, Chastre E, Vaillant J, Gespach C, Capella G, Kalthoff H, Lluis F, Vaysse N, Susini C. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res 56:1823-1827, 1996.
11. van Hagen PM, Krenning EP, Reubi JC, Kwekkeboom D, Oei HY, Mulder AH, Laissue J, Hoogstede HC, Lamberts SWJ. Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med 21 :497-502,1994.
12. Reubi JC, Mazzucchelli L, Laissue J. Intestinal vessels express a high density of somatostatin receptors in human inflammatory bowel disease. Gastroenterology 106:951-959,1994.
13. Reubi JC, Laissue JA. Multiple pathways of somatostatin action in neoplastic disease. Trends Pharmacol Sci 16:110-115, 1995.
14. Krenning EP, Kwekkeboom DJ, Pauwels S, Kvols LK, Reubi JC. Somatostatin receptor scintigraphy. In: Freeman LM, ed. Nuclear Medicine Annual. New York: Raven Press, 1995; 1-50.
15. Kvols LK, Reubi JC, Horisberger U, Moertel CG, Rubin J, Charboneau JW. The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide. Yale J Biol Med 65:505-518, 1992.
16. Moertel CL, Reubi JC, Scheithauer BS, Schaid DJ, Kvols LK. Expression of somatostatin receptors in childhood neuroblastoma. Am J Clin Pathol 102:752-756,1994.
17. O'Dorisio MS, Chen F, O'Dorisio M, Wray D, Qualman SJ. Characterization of somatostatin receptors on human neuroblastoma tumors. Cell Growth Differ 5:1-8, 1994.
18. Krenning EP, Valkema R, Kooij PPM, Breeman WAP, Bakker WH, de Herder WW, van Eijck CHJ, Kwekkeboom DJ, Postema PTE, Kvols LK, Reubi JC, Pauwels S. Radionuclide therapy with (111-In-DTPA-D-Phe-1)-octreotide. Preliminary data of a phase 1 study. In: Continuing Education Course Manual. Reston, VA: Society of Nuclear Medicine, 1996; 148-156.
19. Reubi JC. In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging. J Nucl Med 36:1846-1853, 1995.
20. Virgolini I, Raderer M, Kurtaran A, Angelberger P, Banyai S, Yang Q, Li S, Banyai M, Pidlich J, Niederle B, Scheithauer W, Valent P. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N Engl J Med 331:1116-1121, 1994.
21. Hennig IM, Laissue JA, Horisberger U, Reubi JC. Substance P receptors in human primary neoplasms: tumoural and vascular localisation. Int J Cancer 61:786-792, 1995.
22. Mantyh CR, Gates TS, Zimmerman RP, Welton ML, Passaro EP, Vigna SR, Maggio JE, Kruger L, Mantyh PW. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci USA 85:3235-3239, 1988.
23. Walsh DA, Mapp PI, Wharton J, Rutherdorf RAD, Kidd BL, Revell PA, Blake DR, Polak JM. Localisation and characterisation of substance P binding to human synovial tissue in rheumatoid arthritis. Ann Rheum Dis 51:313-317, 1992.
24. Reubi JC, Waser B. Unexpected high incidence of cholecystokinin B/gastrin receptors in human medullary thyroid carcinomas. Int J Cancer 67:644-647, 1996.
25. Matsumori Y, Katakami N, Ito M, Taniguchi T, Iwata N, Takaishi T, Chihara K, Matsui T. Cholccystokinin-B/gastrin receptor. A novel molecular probe for human small cell lung cancer. Cancer Res 55:276-279,1995.
26. Reubi JC, Horisberger U, Lang W, Koper JW, Braakman R, Lamberts SWJ. Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors. Am J Pathol 134:337-344, 1989.
27. Moody TW. Peptides and growth factors in non-small cell lung cancer. Peptides 17:545-555, 1996.
28. Zola H. Analysis of receptors for cytokines and growth factors in human disease. Disease Markers 12:225-240, 1996.
29. Reubi JC. High incidence of CCK-B/gastrin receptors in human medullary thyroid cancers and small cell lung cancers: differential diagnostic implications. J Nucl Med 37:348P, 1996.